Trials / Unknown
UnknownNCT02143349
The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome
Investigation of Appetite Suppressant Properties Associated With Coleus Forskohlii in Overweight and Obese Individuals
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- Olive Lifesciences Pvt Ltd · Industry
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Coleus forskohlii extract | Ingestion of 250 mg Coleus forskohlii extract capsule twice a day for 12 weeks |
| OTHER | Placebo | Ingestion of 250 mg placebo capsule twice a day for 12 weeks |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-05-01
- Completion
- 2015-05-01
- First posted
- 2014-05-21
- Last updated
- 2014-05-21
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT02143349. Inclusion in this directory is not an endorsement.